Research presented this week at the Annual Scientific Meeting of AACC (the American Association for Clinical Chemistry) indicates that a substantial number of prescription opioid users being monitored for compliance or illicit use are misusing the anti-seizure medication gabapentin.
Testing samples derived mainly from pain clinics in three states found a one-in-five prevalence of positive tests for gabapentin in this patient group, ARIA Diagnostics reported. Physicians generally do not screen for abuse of gabapentin when testing for compliance with other medication regimens, but use of the drug can enhance a high among those using opioids or other drug classes.
According to the Drug Abuse Warning Network (DAWN), visits to emergency departments in metropolitan areas for gabapentin misuse increased by five times from 2008-2011.
Get the latest information on Substance Abuse and other valuable topics at the summit where solutions are formulated, stakeholders convene, and change begins on addressing the opioid crisis.